Taken together, RFA combined with other anti-cancer approaches (i.e. sorafenib, transarterial chemoembolization, and chloroquine) exerts a better curative effect in terms of tumor suppression than RFA alone, probably through inhibiting HIF-1α. The gene discussed is HIF1A; the disease is neoplasm.